Brillian Pharma

Brillian Pharma Inc., a U.S.-based company, focuses on the research and development of high-end generic drugs and pediatric 505b2 improved drugs. Its formulation and controlled-release technologies are above the industry average. The company's self-developed pediatric 505b2 drug platform addresses current shortcomings in pediatric medications by developing liquid oral drugs with numerous advantages, significantly improving compliance among pediatric patients.